2,422
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia

ORCID Icon, , , , , , & show all
Pages 207-212 | Received 09 Aug 2020, Accepted 22 Nov 2020, Published online: 10 Feb 2021

References

  • Cao, P., et al., 2019. The preventative effects of procyanidin on binge ethanol-induced lipid accumulation and ros overproduction via the promotion of hepatic autophagy. Molecular nutrition & food research, 63 (18), e1801255.
  • Cao, P., et al., 2020. The important role of polysaccharides from a traditional Chinese medicine-lung cleansing and detoxifying decoction against the COVID-19 pandemic. Carbohydrate polymers, 240, 116346.
  • Chen, G., et al., 2020. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. Journal of clinical investigation, 130 (5), 2620–2629.
  • Chen, X., et al., 2020. Hypertension and diabetes delay the viral clearance in COVID-19 patients. medRxiv, 2020.03.22.20040774
  • Huang, C., et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395 (10223), 497–506.
  • Jordan, R.E., Adab, P., and Cheng, K.K., 2020. Covid-19: risk factors for severe disease and death. BMJ, 368, m1198.
  • Jung, J.Y., et al., 2019. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population. Hepatology international, 13 (2), 222–233.
  • Kappert, K., Jahic, A., and Tauber, R., 2020. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers, 25 (8), 616–625.
  • Koperdanova, M. and Cullis, J.O., 2015. Interpreting raised serum ferritin levels. BMJ, 351, h3692.
  • Kowdley, K.V., et al., 2012. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology, 55 (1), 77–85.
  • Mantovani, A., Beatrice, G., and Dalbeni, A., 2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis. Liver international, 40 (6), 1316–1320.
  • Mehta, P., et al., 2020. Hlh across speciality collaboration, COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet, 395 (10229), 1033–1034.
  • Shah, R.A. and Kowdley, K.V., 2019. Serum ferritin as a biomarker for NAFLD: ready for prime time? Hepatology international, 13 (2), 110–112.
  • Sun, Y., et al., 2020. Characteristics and prognostic factors of disease severity in patients with COVID-19: the Beijing experience. Journal of autoimmunity, 112, 102473.
  • Tan, C., et al., 2020. C-reactive protein correlates with CT findings and predicts severe COVID-19 early. Journal of medical virology, 92 (7), 856–862.
  • Tan, L., et al., 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal transduction and targeted therapy, 5 (1), 33.
  • Trombini, P. and Piperno, A., 2007. Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons. Journal of hepatology, 46 (4), 549–552.
  • Wu, C., et al., 2020. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 180 (7), 934.
  • Wu, F., et al., 2020. A new coronavirus associated with human respiratory disease in China. Nature, 579 (7798), 265–269.
  • Xie, H., et al., 2020. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study. Liver international, 40 (6), 1321–1326.
  • Xu, L., et al., 2020. Liver injury during highly pathogenic human coronavirus infections. Liver international, 40 (5), 998–1004.
  • Zhang, C., Shi, L., and Wang, F.S., 2020. Liver injury in COVID-19: management and challenges. The lancet. Gastroenterology & hepatology, 5 (5):428–430.
  • Zhang, Y., et al., 2020. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China. Liver international, 40 (9), 2095–2103.
  • Zhou, F., et al., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395 (10229), 1054–1062.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.